We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTA icon
5351
CALL
Enanta Pharmaceuticals
ENTA
$400M
$546K ﹤0.01%
9,300
-1,900
-17% -$95.1K
NBB icon
5352
Nuveen Taxable Municipal Income Fund
NBB
$453M
$546K ﹤0.01%
+24,847
New +$540K
NTLA icon
5353
CALL
Intellia Therapeutics
NTLA
$1.67B
$546K ﹤0.01%
28,400
+13,400
+89% +$309K
MNTA
5354
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$546K ﹤0.01%
+39,107
New +$529K
BMA icon
5355
CALL
Banco Macro
BMA
$5.35B
$545K ﹤0.01%
4,700
+1,900
+68% +$223K
CURE icon
5356
CALL
Direxion Daily Healthcare Bull 3X ETF
CURE
$182M
$545K ﹤0.01%
11,700
+5,700
+95% +$264K
HTT
5357
PUT
High Templar Tech Ltd
HTT
$391M
$545K ﹤0.01%
+43,500
New +$839K
XSD icon
5358
State Street SPDR S&P Semiconductor ETF
XSD
$3.04B
$545K ﹤0.01%
+7,813
New +$547K
PRMW
5359
PUT
DELISTED
Primo Water Corporation
PRMW
$545K ﹤0.01%
+32,700
New +$525K
MLPI
5360
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
$544K ﹤0.01%
22,469
-56,898
-72% -$1.35M
TX icon
5361
PUT
Ternium
TX
$10.6B
$543K ﹤0.01%
+17,200
New +$515K
NXTM
5362
CALL
DELISTED
NxStage Medical Inc.
NXTM
$543K ﹤0.01%
22,400
+4,000
+22% +$105K
CDW icon
5363
PUT
CDW
CDW
$17B
$542K ﹤0.01%
7,800
+3,900
+100% +$268K
CHD icon
5364
PUT
Church & Dwight Co
CHD
$24.5B
$542K ﹤0.01%
10,800
+6,600
+157% +$309K
PENG
5365
Penguin Solutions Inc
PENG
$2.99B
$542K ﹤0.01%
32,170
-10,628
-25% -$169K
CPE
5366
PUT
DELISTED
Callon Petroleum Company
CPE
$542K ﹤0.01%
4,460
+1,820
+69% +$202K
LII icon
5367
CALL
Lennox International
LII
$15.2B
$541K ﹤0.01%
2,600
-4,700
-64% -$917K
ARGO
5368
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$541K ﹤0.01%
10,094
-181,508
-95% -$9.72M
HELE icon
5369
CALL
Helen of Troy
HELE
$693M
$540K ﹤0.01%
5,600
MD icon
5370
PUT
Pediatrix Medical
MD
$2.2B
$540K ﹤0.01%
10,100
+5,000
+98% +$236K
PRTA icon
5371
PUT
Prothena Corp
PRTA
$450M
$540K ﹤0.01%
14,400
+11,200
+350% +$570K
CEVA icon
5372
CEVA Inc
CEVA
$1.08B
$539K ﹤0.01%
11,688
-28,651
-71% -$1.32M
EEFT icon
5373
PUT
Euronet Worldwide
EEFT
$2.7B
$539K ﹤0.01%
6,400
-100
-2% -$9.26K
SEIC icon
5374
CALL
SEI Investments
SEIC
$12.6B
$539K ﹤0.01%
7,500
+700
+10% +$46.9K
VNET
5375
VNET Group
VNET
$2.09B
$539K ﹤0.01%
67,541
+54,920
+435% +$400K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.